glp-1 antibody Engineering of a analogue peptide/anti-PCSK9 fusion for type 2 diabetes treatment Cited in 1 publication Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R

demonstrated that the proximal tubules response to injury can diverge into either adaptive repair or a maladaptive, pro-fibrotic state ( in vivo was shown to shift the balance toward adaptive repair and ameliorate fibrosis, directly illustrating the therapeutic potential of targeting specific disease-associated cell states identified through scRNA-seq ( 4.2 Computational trajectory analysis of kidney cells in DKD Single-cell RNA sequencing has progressively expanded into a diverse range of sophisticated analytical frameworks

10.1080/10286020903510636 22 BlythB

(2010) used 10 mcg/kg and 10 ng/kg in rats, both effective

This is where third-party testing becomes non-negotiable

Abstract Disease caused by plasticizers has received increasing attention